Advertisement

OptimizeRx Corporation OPRX

Set alert

Price alert · OPRX

All alert types
9.32 USD -0.05 -0.53%

At close · Oct 30

9.20 -0.12 -1.29%

After hours · Oct 30, 4:00 PM ET

Bid
9.25 × 2
Ask
9.32 × 2
9.03 Day range 9.36
4.54 52-week range 20.49
YTD
-23.98%
1 year
-52.47%
Open
9.25
Prev close
9.37
Mkt cap
175.55M
Vol
136.55K
Avg vol
182.57K
EPS
0.24
P/E
38.83
Div yield
0.00%
More statistics
Low
9.03
High
9.36
Forward P/E
9.86
Beta
0.00
Short ratio
2.70
Inst. own
68.94%
Dividend
0.00
Ex-div date
50-d avg
5.40
200-d avg
8.91
1y target
10.36

2Y chart

Chart tools
Interval

Events in this range
  • Nov 13, 2024Earnings: 0.12; estimate 0.06; surprise 100%
  • Nov 14, 2024Rating: JMP Securities · Market Outperform → Market Outperform
  • Nov 14, 2024Rating: Barclays · Equal-Weight → Equal-Weight
  • Nov 14, 2024Rating: Stifel · Buy → Buy
  • Nov 14, 2024Rating: Roth MKM · Buy → Buy
  • Nov 14, 2024Rating: RBC Capital · Outperform → Outperform
  • Dec 20, 2024Rating: Stephens & Co. · — → Equal-Weight
Signals (72)
NameDateAgo
MACD: Buy SignalOct 19, 20261 week ago
MACD: Sell SignalOct 16, 20262 weeks ago
MACD: Buy SignalOct 15, 20262 weeks ago
MACD: Sell SignalOct 12, 20262 weeks ago
SMA: BullishSep 29, 20261 month ago
SMA: BearishSep 28, 20261 month ago
MACD: Buy SignalSep 25, 20261 month ago
SMA: BullishSep 24, 20261 month ago
MACD: Sell SignalAug 24, 20262 months ago
RSI: OverboughtAug 13, 20262 months ago
MACD: Buy SignalAug 5, 20262 months ago
MACD: Sell SignalJul 23, 20263 months ago
RSI: OverboughtJul 15, 20263 months ago
SMA: BullishJun 30, 20264 months ago
MACD: Buy SignalJun 26, 20264 months ago
MACD: Sell SignalJun 23, 20264 months ago
MACD: Buy SignalJun 1, 20265 months ago
MACD: Sell SignalMay 13, 20265 months ago
RSI: OversoldMay 13, 20265 months ago
SMA: BearishMay 5, 20265 months ago
SMA: BullishMay 4, 20266 months ago
MACD: Buy SignalMar 13, 20267 months ago
MACD: Sell SignalMar 12, 20267 months ago
RSI: OversoldMar 12, 20267 months ago
RSI: OversoldMar 10, 20267 months ago
RSI: OversoldMar 6, 20267 months ago
MACD: Buy SignalMar 4, 20268 months ago
RSI: OversoldMar 2, 20268 months ago
RSI: OversoldFeb 23, 20268 months ago
RSI: OversoldFeb 17, 20268 months ago
RSI: OversoldFeb 11, 20268 months ago
RSI: OversoldFeb 3, 20269 months ago
MACD: Sell SignalJan 20, 20269 months ago
MACD: Buy SignalDec 18, 202510 months ago
MACD: Sell SignalDec 16, 202510 months ago
SMA: BearishDec 12, 202510 months ago
MACD: Buy SignalNov 28, 202511 months ago
SMA: BearishNov 7, 202511 months ago
SMA: BullishNov 5, 202512 months ago
SMA: BearishNov 4, 202512 months ago
MACD: Sell SignalOct 31, 20251 year ago
MACD: Buy SignalOct 24, 20251 year ago
MACD: Sell SignalOct 22, 20251 year ago
MACD: Buy SignalOct 15, 20251 year ago
MACD: Sell SignalOct 2, 20251 year ago
MACD: Buy SignalSep 29, 20251 year ago
MACD: Sell SignalSep 9, 20251 year ago
SMA: BullishAug 8, 20251 year ago
MACD: Buy SignalAug 8, 20251 year ago
RSI: OverboughtAug 8, 20251 year ago
SMA: BearishJul 29, 20251 year ago
MACD: Sell SignalJul 29, 20251 year ago
MACD: Buy SignalJul 24, 20251 year ago
MACD: Sell SignalJun 16, 20251 year ago
RSI: OverboughtJun 4, 20251 year ago
RSI: OverboughtMay 19, 20251 year ago
RSI: OverboughtMay 2, 20251 year ago
MACD: Buy SignalApr 29, 20251 year ago
MACD: Sell SignalApr 2, 20251 year ago
RSI: OverboughtMar 14, 20251 year ago
MACD: Buy SignalMar 13, 20251 year ago
SMA: BullishMar 12, 20251 year ago
SMA: BearishFeb 25, 20251 year ago
MACD: Sell SignalFeb 24, 20251 year ago
RSI: OverboughtFeb 14, 20251 year ago
MACD: Buy SignalFeb 13, 20251 year ago
MACD: Sell SignalFeb 12, 20251 year ago
MACD: Buy SignalJan 22, 20251 year ago
SMA: BullishJan 21, 20251 year ago
MACD: Sell SignalJan 14, 20251 year ago
MACD: Buy SignalDec 26, 20241 year ago
MACD: Sell SignalDec 19, 20241 year ago

Key statistics

Market cap
88.97M
Enterprise value
118.13M
Trailing P/E
0.00
Forward P/E
9.86
PEG ratio
0.00
Price / sales
1.01
Price / book
0.85
EPS (TTM)
-1.34
Beta
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-27.41%
Revenue (TTM)
88.18M
Revenue growth
30.50%
Free cash flow
8.35M
Total cash
16.13M
Total debt
35.72M
Return on equity
-20.97%
Shares outstanding
18.42M
Short % of float
5.68%
50-day average
5.40
200-day average
8.91

Analyst view

Consensus: buy

Buy
Price target (mean) 10.36 +11.1% upside
Target (low)
5.50
Target (mean)
10.36
Target (high)
17.00
Ratings (0m) 8 7 buy · 1 hold · 0 sell
  • Strong buy3
  • Buy4
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate 0.25.

Earnings history

Financials — quick view

All financials
OPRX Revenue — quarterly 20.50M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
OPRX Net income — quarterly -703.00K
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
OPRX EPS — quarterly -0.04
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

OPRX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 13, 2024Sep 1, 20240.060.12+0.06+100.00%
Aug 8, 2024Jun 1, 2024-0.070.02+0.09+128.57%
May 14, 2024Mar 1, 2024-0.11-0.110.000.00%
Apr 16, 2024Dec 1, 20230.000.26——
Nov 6, 2023Sep 1, 20230.020.09+0.07+350.00%
Aug 14, 2023Jun 1, 2023-0.02-0.01+0.01+50.00%

Upgrades / downgrades

OPRX analyst upgrades and downgrades
DateFirmActionFromTo
Dec 20, 2024Stephens & Co.init—Equal-Weight
Nov 14, 2024RBC CapitalmainOutperformOutperform
Nov 14, 2024Roth MKMreitBuyBuy
Nov 14, 2024StifelmainBuyBuy
Nov 14, 2024BarclaysmainEqual-WeightEqual-Weight
Nov 14, 2024JMP SecuritiesmainMarket OutperformMarket Outperform

About OptimizeRx Corporation

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

Sector
Healthcare
Industry
Health Information Services
Country
United States

News

Your note

Sign in to keep a note on OPRX — it syncs with the Stock Master app.

Insider holders

OPRX insider holders
InsiderRelationLatest transactionDateShares held
BESCH DOUGOfficerConversion of Exercise of derivative securityDec 18, 202411,583
FEBBO WILLIAM JChief Executive OfficerPurchaseDec 11, 2024601,253
KLEMA CATHERINE MDirectorStock Award(Grant)Jun 6, 20246,643
LANG JAMES PAULDirectorStock Award(Grant)Jun 6, 202468,044
ODENCE-FORD MARION K.General CounselConversion of Exercise of derivative securityDec 18, 202427,230
SILVESTRO STEPHEN LOfficerConversion of Exercise of derivative securityDec 18, 202480,848

Institution ownership

OPRX institution ownership
Holder% heldSharesValueReported
First Light Asset Management, LLC14.98%1,811,6118.75MSep 29, 2024
Blackrock Inc.10.54%1,274,7616.16MSep 29, 2024
AWM Investment Company, Inc.8.86%1,071,8325.18MSep 29, 2024
Samjo Management, LLC8.64%1,044,8005.05MSep 29, 2024
Vanguard Group Inc7.88%952,8934.60MSep 29, 2024
Blair (William) & Company, L.L.C.5.60%677,0943.27MSep 29, 2024

Fund ownership

OPRX fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund4.19%506,6912.45MSep 29, 2024
iShares Russell 2000 ETF3.75%453,8482.19MOct 30, 2024
Jacob Internet Fund2.30%278,2751.34MOct 30, 2024
Vanguard Extended Market Index Fund2.23%270,2681.31MSep 29, 2024
Fidelity Small Cap Index Fund1.51%182,433881.15KAug 30, 2024
iShares Russell 2000 Growth ETF1.29%156,029753.62KOct 30, 2024
Advertisement